Expands GEN-1 Program Collaboration to AddClinical and Commercial Batches of Investigational Vaccine
LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based…

Click here to view the original article.